Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Janowsky

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Psychopharmacology|January 6, 2012
Substituted heteroaromatic compounds: effect on nicotine self-administration in ratsJohn R Cashman, Karl Okolotowicz, Matt Cerny, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2004
Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model systemClare J Wilhelm, Robert A Johnson, Paul G Lysko, et al.
Neurotoxicology|September 19, 2017
Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicityNicholas B Miner, Josh S Elmore, Michael H Baumann, et al.
Journal of Medicinal Chemistry|September 6, 2002
Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporterWilliam J Houlihan, Lawrence Kelly, Jessica Pankuch, et al.
Plos One|October 11, 2019
Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependenceJennifer M Loftis, Michael Lasarev, Xiao Shi, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanesMadhusudhan Purushotham, Anjaneyulu Sheri, Duy-Phong Pham-Huu, et al.
Psychopharmacology|October 22, 2013
Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and functionAmy J Eshleman, Michael J Forster, Katherine M Wolfrum, et al.
Cellular and Molecular Neurobiology|April 26, 2006
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677Piotr Popik, Martyna Krawczyk, Krystyna Golembiowska, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Combining the alpha-2 adrenergic agonist clonidine with naloxone rescues fentanyl-induced physiologic dysfunction and increases survivalAlyssa Rivera, William E Schutzer, Alex Sonneborn, et al.
Biochemical Pharmacology|September 28, 2018
Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT<sub>2A</sub> receptorsAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Psychopharmacology|January 6, 2012
Substituted heteroaromatic compounds: effect on nicotine self-administration in ratsJohn R Cashman, Karl Okolotowicz, Matt Cerny, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2004
Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model systemClare J Wilhelm, Robert A Johnson, Paul G Lysko, et al.
Neurotoxicology|September 19, 2017
Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicityNicholas B Miner, Josh S Elmore, Michael H Baumann, et al.
Journal of Medicinal Chemistry|September 6, 2002
Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporterWilliam J Houlihan, Lawrence Kelly, Jessica Pankuch, et al.
Plos One|October 11, 2019
Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependenceJennifer M Loftis, Michael Lasarev, Xiao Shi, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanesMadhusudhan Purushotham, Anjaneyulu Sheri, Duy-Phong Pham-Huu, et al.
Psychopharmacology|October 22, 2013
Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and functionAmy J Eshleman, Michael J Forster, Katherine M Wolfrum, et al.
Cellular and Molecular Neurobiology|April 26, 2006
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677Piotr Popik, Martyna Krawczyk, Krystyna Golembiowska, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Combining the alpha-2 adrenergic agonist clonidine with naloxone rescues fentanyl-induced physiologic dysfunction and increases survivalAlyssa Rivera, William E Schutzer, Alex Sonneborn, et al.
Biochemical Pharmacology|September 28, 2018
Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT<sub>2A</sub> receptorsAmy J Eshleman, Katherine M Wolfrum, John F Reed, et al.
Pageof 7